Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents (NCT05347771)

🧪 Interventions in This Study

• Dupilumab (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (8 Sites)

• Children's Hospital Colorado: Allergy Program — Aurora, Colorado
• Children's National Medical Center: Children's Research Institute — Washington D.C., District of Columbia
• Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology — Chicago, Illinois
• Boston Children's Hospital: Department of Immunology — Boston, Massachusetts
• Washington University at St. Louis — St Louis, Missouri
• Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute — New York, New York
• Columbia University Medical Center: Division of Pediatric Pulmonology — New York, New York
• Cincinnati Children's Hospital Medical Center: Asthma Center — Cincinnati, Ohio

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Asthma

• Investigating Dupilumab's Effect in Asthma by Genotype — Boston, Massachusetts
• Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma — Bakersfield, California
• Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma — Saraland, Alabama
• Reduce IDentified UNcontrolled Asthma — San Diego, California
• A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma — Little Rock, Arkansas
• REIMAGINE - Real World EvaluatIon of Mepolizumab in Severe Asthma achievinG on Treatment clinIcal remissioN, a prospEctive Study — La Jolla, California

Explore by condition: All Asthma clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.